LC-MS profile and in vivo oral acute toxicity, antihypertensive and vascular endothelium protective effects of phenolic compounds of the ethyl acetate fraction of leafy stems of Flemingia faginea Guill. & Perr. in L-NAME induced hypertensive mice

Windingoudi Rimwagna Christian Ouedraogo , Lazare Belemnaba , Mathieu Nitiéma , Boukaré Kaboré , Bonéwendé Mohamed Belemlilga , Moumouni Koala , Raogo Ouedraogo , Rasmané Semdé , Sylvin Ouedraogo
{"title":"LC-MS profile and in vivo oral acute toxicity, antihypertensive and vascular endothelium protective effects of phenolic compounds of the ethyl acetate fraction of leafy stems of Flemingia faginea Guill. & Perr. in L-NAME induced hypertensive mice","authors":"Windingoudi Rimwagna Christian Ouedraogo ,&nbsp;Lazare Belemnaba ,&nbsp;Mathieu Nitiéma ,&nbsp;Boukaré Kaboré ,&nbsp;Bonéwendé Mohamed Belemlilga ,&nbsp;Moumouni Koala ,&nbsp;Raogo Ouedraogo ,&nbsp;Rasmané Semdé ,&nbsp;Sylvin Ouedraogo","doi":"10.1016/j.prenap.2025.100189","DOIUrl":null,"url":null,"abstract":"<div><div>The present study aimed at evaluating <em>in vivo</em> the antihypertensive and vascular endothelium protection effects of the ethyl acetate fraction of the leafy stem of <em>Flemingia. faginea</em> (EAF) in hypertensive mice with Lῳ- Nitro Arginine Methyl Ester (L-NAME). <strong>Methods</strong>: Six (06) groups (n = 7) of mice were formed for the study, which lasted five weeks. Groups I, II, and III were administered parenterally with L-NAME (80 mg/kg), NaCl 0.9 % (0.5 mL/kg), and EAF (24 mg/kg) for four weeks, respectively. Mice in groups IV, V, VI, and VII received only L-NAME (80 mg/kg) for two weeks and then received L-NAME plus treatment respectively, captopril 5 mg/kg, 6; 12, and 24 mg/kg for the following two weeks. The acute oral toxicity and phytochemical analysis of EAF were carried out. <strong>Results</strong>: Daily administration of the L-NAME resulted in a significant increase in BP characterized by SBP= 164.32 ± 6.40 mmHg and DBP= 91.00 ± 0.83 mmHg for all groups concerned on day 21 (<em>p</em> &lt; 0.001). A statistically significant decrease in BP was observed from day seven for the hypertensive mice groups treated with 6; 12, and 24 mg/kg of EAF, and Captopril (5 mg/kg) <em>versus</em> L-NAME (80 mg/kg) only. Aortic rings of mice in the L-NAME+EAF 24 mg/kg group (E<sub>max</sub>=69.21±2.70 % and EC<sub>50</sub>=5.08 ± 0.37 ×10<sup>−7</sup> M) showed more effective and potent nitric oxide (NO) endothelium-dependent vasorelaxation than the reference group L-NAME+Captopril 5 mg/kg (E<sub>max</sub>=49.64±7.67 %). The 50 % lethal dose of EAF was estimated to be 5000 mg/kg. Phytochemical analysis identified mainly gallic acid glucoside, myricetin rutinoside, quercetin rutinoside, kaempferol rutinoside, and quercetin rhamnoside. <strong>Conclusion:</strong> These results suggest that EAF, a potential drug candidate, could be used preventively and curatively to manage hypertension.</div></div>","PeriodicalId":101014,"journal":{"name":"Pharmacological Research - Natural Products","volume":"6 ","pages":"Article 100189"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacological Research - Natural Products","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2950199725000497","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The present study aimed at evaluating in vivo the antihypertensive and vascular endothelium protection effects of the ethyl acetate fraction of the leafy stem of Flemingia. faginea (EAF) in hypertensive mice with Lῳ- Nitro Arginine Methyl Ester (L-NAME). Methods: Six (06) groups (n = 7) of mice were formed for the study, which lasted five weeks. Groups I, II, and III were administered parenterally with L-NAME (80 mg/kg), NaCl 0.9 % (0.5 mL/kg), and EAF (24 mg/kg) for four weeks, respectively. Mice in groups IV, V, VI, and VII received only L-NAME (80 mg/kg) for two weeks and then received L-NAME plus treatment respectively, captopril 5 mg/kg, 6; 12, and 24 mg/kg for the following two weeks. The acute oral toxicity and phytochemical analysis of EAF were carried out. Results: Daily administration of the L-NAME resulted in a significant increase in BP characterized by SBP= 164.32 ± 6.40 mmHg and DBP= 91.00 ± 0.83 mmHg for all groups concerned on day 21 (p < 0.001). A statistically significant decrease in BP was observed from day seven for the hypertensive mice groups treated with 6; 12, and 24 mg/kg of EAF, and Captopril (5 mg/kg) versus L-NAME (80 mg/kg) only. Aortic rings of mice in the L-NAME+EAF 24 mg/kg group (Emax=69.21±2.70 % and EC50=5.08 ± 0.37 ×10−7 M) showed more effective and potent nitric oxide (NO) endothelium-dependent vasorelaxation than the reference group L-NAME+Captopril 5 mg/kg (Emax=49.64±7.67 %). The 50 % lethal dose of EAF was estimated to be 5000 mg/kg. Phytochemical analysis identified mainly gallic acid glucoside, myricetin rutinoside, quercetin rutinoside, kaempferol rutinoside, and quercetin rhamnoside. Conclusion: These results suggest that EAF, a potential drug candidate, could be used preventively and curatively to manage hypertension.
flmingia faginea Guill叶茎乙酸乙酯部位酚类化合物的体内口服急性毒性、抗高血压和血管内皮保护作用&穗青葱。L-NAME诱导的高血压小鼠
本研究旨在体内评价Flemingia叶茎乙酸乙酯部位的降压和血管内皮保护作用。L-氨基精氨酸甲酯(L- name)对高血压小鼠的影响。方法:取6组(06)只小鼠(n = 7)进行实验,实验时间为5周。I组、II组和III组分别给予L-NAME(80 mg/kg)、NaCl 0.9 %(0.5 mL/kg)和EAF(24 mg/kg),持续4周。IV、V、VI、VII组小鼠仅给予L-NAME(80 mg/kg)治疗2周后,分别给予L-NAME加药、卡托普利5 mg/kg、6;12, 24 mg/kg,持续两周。对EAF进行了急性口服毒性和植物化学分析。结果:日常管理L-NAME导致显著增加的英国石油公司以SBP = 164.32 ±6.40  91.00毫米汞柱和菲律宾=  ±0.83  毫米汞柱对所有有关团体在21天(p & lt; 0.001)。高血压小鼠组从第7天开始血压下降有统计学意义;EAF为12、24 mg/kg,卡托普利为5 mg/kg,而L-NAME为80 mg/kg。L-NAME+EAF 24 mg/kg组(Emax=69.21±2.70 %,EC50=5.08 ± 0.37 ×10−7 M)对小鼠主动脉环的一氧化氮(NO)内皮依赖性血管舒张作用明显优于对照组(L-NAME+卡托普利5 mg/kg, Emax=49.64±7.67 %)。EAF的50% %致死剂量估计为5000 mg/kg。植物化学分析主要鉴定没食子酸葡萄糖苷、杨梅素芦丁苷、槲皮素芦丁苷、山奈酚芦丁苷和槲皮素鼠李糖苷。结论:EAF是一种潜在的治疗高血压的候选药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信